Sort
46,585 grants matching “heart failure”
Myocardial Hypertrophy and Heart Failure
$1,451,551Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2003 · HL
Development of the Predictive NeuroCardiovascular Simulator
$1,450,692Colleen E Clancy · University Of California At Davis · OT2 · FY2020 · OD
Late Sodium Current Blockade in High-Risk ICD Patients - CCC - Lead Application
$1,449,353Wojciech Zareba · University Of Rochester · U01 · FY2010 · HL
Biomarker Profiles in the Diagnosis/Prognosis of ARDS
$1,449,150Lorraine B Ware · Vanderbilt University · U01 · FY2008 · HL
FAMILIAL HYPERTROPHIC CARDIOMYOPATHY--SARCOMERIC DISEASE
$1,449,031University Of Vermont &St Agric College · P01 · FY2001 · HL
Action for Health in Diabetes (Look AHEAD)
$1,448,126David M Nathan · Massachusetts General Hospital · U01 · FY2007 · DK
Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing
$1,447,258Syed Mukhtar Ahmed · Greenstone Biosciences, Inc. · R44 · FY2024 · HL
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
$1,445,795Jason D Christie · University Of Pennsylvania · U01 · FY2023 · HL
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
$1,445,795Jason D Christie · University Of Pennsylvania · U01 · FY2025 · HL
Center for Cardiovascular Outcomes Research at Yale University
$1,445,090Harlan M Krumholz · Yale University · U01 · FY2012 · HL
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
$1,444,837D. Martin Watterson · Northwestern University At Chicago · U01 · FY2023 · AG
Nonmyeloablative allogeneic PBSC in globin disorders
$1,443,650John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2020 · HL
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
$1,441,891Dalane W Kitzman · Wake Forest University Health Sciences · R01 · FY2017 · AG
Biomarkers of Parkinson Disease and Related Disorders
$1,441,785David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS
Determinants and Cardiovascular Consequences of Diabetes in Older Adults
$1,440,971Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
Long Term Follow up of the Lung Transplant Outcomes Group Cohort
$1,440,473Jason D Christie · University Of Pennsylvania · U01 · FY2019 · HL
Pivotal Preclinical Studies of Novel Infusible ECM for Treating Acute MI
$1,440,231Adam M Kinsey · Ventrix, Inc. · R44 · FY2024 · HL
JHS TRAINING AND EDUCATION CENTER NHLBI FUNDING 9/15/2025 - 9/14/2026
$1,439,525Asoka S Srinivasan · Tougaloo College · N01 · FY2025 · HL
NDA-Enabling Phase I Lofexidine Program
$1,438,532James Alvan Longstreth · Us Worldmeds, Llc · U01 · FY2014 · DA
Genetically-engineered pig organ transplantation into nonhuman primates
$1,438,261David Kc Cooper · University Of Pittsburgh At Pittsburgh · U19 · FY2013 · AI
Comparative Effectiveness of Comprehensive Care for Adults with SMI
$1,438,166Todd Patrick Gilmer · University Of California, San Diego · R01 · FY2010 · HS
Cardiovascular Toxicity of Environmental Aldehydes
$1,437,761Aruni Bhatnagar Bhatnagar · University Of Louisville · P01 · FY2006 · ES
Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes
$1,437,743Carolyn Y Ho · Brigham And Women'S Hospital · R01 · FY2023 · HL
The Genetics of Uveal Coloboma
$1,435,953Brian Brooks · National Eye Institute · ZIA · FY2010 · EY
SCAN-MP (Screening for Cardiac Amyloidosiswith Nuclear imaging in Minority Populations)
$1,434,545Mathew S Maurer · Columbia University Health Sciences · R01 · FY2022 · HL